Pricing
Login
Home
Charts
Search
Watchlist
Products

J B Chemicals & Pharmaceuticals Ltd

JBCHEPHARM
₹2,408.900.00%16 Jul 2026
Reports
Pharma Formulations

J B Chemicals & Pharmaceuticals Ltd

JBCHEPHARM
₹2,408.90
0.00%
16 Jul 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹38,677Cr
Close
Close Price
₹2,408.90
Industry
Industry
Pharma Formulations
PE
Price To Earnings
53.22
PS
Price To Sales
9.32
Revenue
Revenue
₹4,148Cr
Rev Gr TTM
Revenue Growth TTM
5.87%
PAT Gr TTM
PAT Growth TTM
7.56%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue
RevenueCr
8968828458621,0041,0019639491,0941,0851,065904
Growth YoY
Revenue Growth YoY%
14.28.96.513.012.113.514.110.28.98.410.5-4.8
Expenses
ExpensesCr
664638621664724730709723793775769703
Operating Profit
Operating ProfitCr
232244223198280271255226301310296201
OPM
OPM%
25.927.626.423.027.927.026.423.927.528.527.822.2
Other Income
Other IncomeCr
68717610814151518-15
Interest Expense
Interest ExpenseCr
121012962311121
Depreciation
DepreciationCr
313234414142424643444550
PBT
PBTCr
194209184165240237218193272279267135
Tax
TaxCr
525850386362564769716933
PAT
PATCr
142151134126177175162146202208198101
Growth YoY
PAT Growth YoY%
35.335.625.944.024.315.921.615.514.419.121.8-30.4
NPM
NPM%
15.917.115.814.617.617.416.915.318.519.218.611.2
EPS
EPS₹
4.69.78.68.211.411.210.59.413.013.312.66.3
QuarterJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue
RevenueCr
8968828458621,0041,0019639491,0941,0851,065904
Growth YoY
Revenue Growth YoY%
14.28.96.513.012.113.514.110.28.98.410.5-4.8
Expenses
ExpensesCr
664638621664724730709723793775769703
Operating Profit
Operating ProfitCr
232244223198280271255226301310296201
OPM
OPM%
25.927.626.423.027.927.026.423.927.528.527.822.2
Other Income
Other IncomeCr
68717610814151518-15
Interest Expense
Interest ExpenseCr
121012962311121
Depreciation
DepreciationCr
313234414142424643444550
PBT
PBTCr
194209184165240237218193272279267135
Tax
TaxCr
525850386362564769716933
PAT
PATCr
142151134126177175162146202208198101
Growth YoY
PAT Growth YoY%
35.335.625.944.024.315.921.615.514.419.121.8-30.4
NPM
NPM%
15.917.115.814.617.617.416.915.318.519.218.611.2
EPS
EPS₹
4.69.78.68.211.411.210.59.413.013.312.66.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
1,1441,2101,3441,4091,6431,7752,0432,4243,1493,4843,9184,148
Growth
Revenue Growth%
5.811.14.816.68.015.118.729.910.612.45.9
Expenses
ExpensesCr
9641,0041,1121,1911,3371,3971,4821,8812,4542,5872,8863,040
Operating Profit
Operating ProfitCr
1802062322183063785605436968971,0321,107
OPM
OPM%
15.717.017.315.518.621.327.422.422.125.726.326.7
Other Income
Other IncomeCr
1158503741411123910373833
Interest Expense
Interest ExpenseCr
7115353753644126
Depreciation
DepreciationCr
3941475756666973114138171183
PBT
PBTCr
146212230194287349597505555752887952
Tax
TaxCr
455046559377148119145199228243
PAT
PATCr
100163184139194272449386410553660709
Growth
PAT Growth%
62.013.4-24.839.840.464.7-13.96.234.819.47.6
NPM
NPM%
8.813.413.79.811.815.322.015.913.015.916.817.1
EPS
EPS₹
5.99.610.98.211.817.129.024.926.535.742.545.2
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
1,1441,2101,3441,4091,6431,7752,0432,4243,1493,4843,9184,148
Growth
Revenue Growth%
5.811.14.816.68.015.118.729.910.612.45.9
Expenses
ExpensesCr
9641,0041,1121,1911,3371,3971,4821,8812,4542,5872,8863,040
Operating Profit
Operating ProfitCr
1802062322183063785605436968971,0321,107
OPM
OPM%
15.717.017.315.518.621.327.422.422.125.726.326.7
Other Income
Other IncomeCr
1158503741411123910373833
Interest Expense
Interest ExpenseCr
7115353753644126
Depreciation
DepreciationCr
3941475756666973114138171183
PBT
PBTCr
146212230194287349597505555752887952
Tax
TaxCr
455046559377148119145199228243
PAT
PATCr
100163184139194272449386410553660709
Growth
PAT Growth%
62.013.4-24.839.840.464.7-13.96.234.819.47.6
NPM
NPM%
8.813.413.79.811.815.322.015.913.015.916.817.1
EPS
EPS₹
5.99.610.98.211.817.129.024.926.535.742.545.2
Sales CAGR
1 Year6%
3 Years10%
5 Years15%
TTM6%
EBITDA CAGR
1 Year7%
3 Years17%
5 Years15%
TTM7%
PAT CAGR
1 Year8%
3 Years20%
5 Years10%
TTM8%
Avg. ROCE
1 Year23%
3 Years24%
5 Years23%
TTM23%
CFO / EBITDA
1 Year64%
3 Years79%
5 Years75%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
171717171615151515161616
Reserves
ReservesCr
9781,1671,3471,4251,4641,4201,7942,1192,4652,9083,4184,143
Current Liabilities
Current LiabilitiesCr
460431281275244313345384554868632591
Non Current Liabilities
Non Current LiabilitiesCr
3331274665697985519203208218
Total Liabilities
Total LiabilitiesCr
1,4871,6481,6741,7651,7921,8212,2382,6073,5543,9944,2744,969
Current Assets
Current AssetsCr
9018167951,0471,0511,0731,5531,2531,5281,8531,9232,909
Non Current Assets
Non Current AssetsCr
5868328797187417476861,3542,0262,1412,3512,059
Total Assets
Total AssetsCr
1,4871,6481,6741,7651,7921,8212,2382,6073,5543,9944,2744,969
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
171717171615151515161616
Reserves
ReservesCr
9781,1671,3471,4251,4641,4201,7942,1192,4652,9083,4184,143
Current Liabilities
Current LiabilitiesCr
460431281275244313345384554868632591
Non Current Liabilities
Non Current LiabilitiesCr
3331274665697985519203208218
Total Liabilities
Total LiabilitiesCr
1,4871,6481,6741,7651,7921,8212,2382,6073,5543,9944,2744,969
Current Assets
Current AssetsCr
9018167951,0471,0511,0731,5531,2531,5281,8531,9232,909
Non Current Assets
Non Current AssetsCr
5868328797187417476861,3542,0262,1412,3512,059
Total Assets
Total AssetsCr
1,4871,6481,6741,7651,7921,8212,2382,6073,5543,9944,2744,969

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
127140201123194276315170626801902704
Investing Cash Flow
Investing Cash FlowCr
-112-28-45-21-2824-2312-962-404-296-586
Financing Cash Flow
Financing Cash FlowCr
-1-100-184-60-156-306-87-138357-385-580-123
Net Cash Flow
Net Cash FlowCr
1313-284311-6-334201127-5
Free Cash Flow
Free Cash FlowCr
56-634894153205294115554675806623
CFO To PAT
CFO To PAT%
126.286.3109.188.7100.2101.270.244.1152.6144.9136.899.2
CFO To EBITDA
CFO To EBITDA%
70.368.286.556.563.573.056.231.389.989.387.563.6
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
127140201123194276315170626801902704
Investing Cash Flow
Investing Cash FlowCr
-112-28-45-21-2824-2312-962-404-296-586
Financing Cash Flow
Financing Cash FlowCr
-1-100-184-60-156-306-87-138357-385-580-123
Net Cash Flow
Net Cash FlowCr
1313-284311-6-334201127-5
Free Cash Flow
Free Cash FlowCr
56-634894153205294115554675806623
CFO To PAT
CFO To PAT%
126.286.3109.188.7100.2101.270.244.1152.6144.9136.899.2
CFO To EBITDA
CFO To EBITDA%
70.368.286.556.563.573.056.231.389.989.387.563.6

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,6972,1152,9432,5842,8853,9299,68812,17315,25025,59925,25433,12638,677
Price To Earnings
Price To Earnings
22.313.016.018.714.914.421.631.637.246.338.346.753.2
Price To Sales
Price To Sales
1.51.82.21.81.82.24.75.04.87.36.58.09.3
Price To Book
Price To Book
1.71.82.21.81.92.75.35.76.28.87.48.09.3
EV To EBITDA
EV To EBITDA
10.011.112.811.99.410.417.322.422.628.924.429.834.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
51.850.650.952.354.856.658.458.356.660.160.662.862.8
OPM
OPM%
15.717.017.315.518.621.327.422.422.125.726.326.726.7
NPM
NPM%
8.813.413.79.811.815.322.015.913.015.916.817.117.1
ROCE
ROCE%
13.616.216.713.419.424.032.623.319.424.126.023.023.0
ROE
ROE%
10.113.713.59.613.119.024.818.116.518.919.217.117.1
ROA
ROA%
6.89.911.07.910.815.020.014.811.513.815.414.314.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,6972,1152,9432,5842,8853,9299,68812,17315,25025,59925,25433,12638,677
Price To Earnings
Price To Earnings
22.313.016.018.714.914.421.631.637.246.338.346.753.2
Price To Sales
Price To Sales
1.51.82.21.81.82.24.75.04.87.36.58.09.3
Price To Book
Price To Book
1.71.82.21.81.92.75.35.76.28.87.48.09.3
EV To EBITDA
EV To EBITDA
10.011.112.811.99.410.417.322.422.628.924.429.834.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
51.850.650.952.354.856.658.458.356.660.160.662.862.8
OPM
OPM%
15.717.017.315.518.621.327.422.422.125.726.326.726.7
NPM
NPM%
8.813.413.79.811.815.322.015.913.015.916.817.117.1
ROCE
ROCE%
13.616.216.713.419.424.032.623.319.424.126.023.023.0
ROE
ROE%
10.113.713.59.613.119.024.818.116.518.919.217.117.1
ROA
ROA%
6.89.911.07.910.815.020.014.811.513.815.414.314.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr46,77844,35141,45838,67735,49928,45122,440
Close PriceClose₹1,843.802,337.803,317.702,408.902,184.401,718.70822.65
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE32.4640.5432.8253.2286.5587.0728.47
Price To SalesPS4.464.336.679.329.4613.553.81
RevenueRevenueCr10,47910,2346,2174,1483,7512,1005,895
Revenue Growth TTMRev Gr TTM%12.0%21.1%25.0%5.9%25.7%46.3%21.8%
PAT Growth TTMPAT Gr TTM%72.8%33.3%29.7%7.6%894.1%89.4%39.1%
Market CapitalizationMkt CapCr46,77844,35141,45838,67735,49928,45122,440
Close PriceClose₹1,843.802,337.803,317.702,408.902,184.401,718.70822.65
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE32.4640.5432.8253.2286.5587.0728.47
Price To SalesPS4.464.336.679.329.4613.553.81
RevenueRevenueCr10,47910,2346,2174,1483,7512,1005,895
Revenue Growth TTMRev Gr TTM%12.0%21.1%25.0%5.9%25.7%46.3%21.8%
PAT Growth TTMPAT Gr TTM%72.8%33.3%29.7%7.6%894.1%89.4%39.1%
Interviews